Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.
Guardado en:
Autores principales: | Naoki Nishio, Nynke S. van den Berg, Stan van Keulen, Brock A. Martin, Shayan Fakurnejad, Nutte Teraphongphom, Stefania U. Chirita, Nicholas J. Oberhelman, Guolan Lu, Crista E. Horton, Michael J. Kaplan, Vasu Divi, A. Dimitrios Colevas, Eben L. Rosenthal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d94d112023644caad227f072f22a399 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
por: Guolan Lu, et al.
Publicado: (2020) -
Benign Inclusions in Lymph Nodes
por: Spinardi,Julia Regazzini, et al.
Publicado: (2007) -
Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways
por: Mohamed F. Ali, et al.
Publicado: (2017) -
Benign macrocystic serous cystadenoma of the pancreas
por: Selma Erdogan Duzcu, et al.
Publicado: (2021) -
Radiofrequency for benign and malign thyroid lesions
por: Leonardo Rangel, et al.
Publicado: (2020)